We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study Reveals Active and Non-Active Structures of the NMDA Receptor

By LabMedica International staff writers
Posted on 12 May 2016
Print article
Image: A diagram showing how different domains of the NMDA receptor move when the receptor is in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for potential use in schizophrenia, depression, and other disorders (Photo courtesy of Furukawa Lab, Cold Spring Harbor Laboratory).
Image: A diagram showing how different domains of the NMDA receptor move when the receptor is in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for potential use in schizophrenia, depression, and other disorders (Photo courtesy of Furukawa Lab, Cold Spring Harbor Laboratory).
Advanced imaging techniques were used to obtain the three-dimensional structure of the NMDA (N-methyl, D-aspartate) receptor in active and non-active states.

The physiology of N-methyl-d-aspartate (NMDA) receptors is fundamental to brain development and function. NMDA receptors are ionotropic glutamate receptors that function as heterotetramers composed mainly of GluN1 (glycine-binding NMDA receptor subunit 1) and GluN2 (glutamate-binding NMDA receptor subunit 2) subunits. Activation of NMDA receptors requires binding of neurotransmitter agonists to a ligand-binding domain (LBD) and structural rearrangement of an amino-terminal domain (ATD). The membrane domain (TMB) contributes residues to the channel pore and is responsible for the receptor's high-unitary conductance, high-calcium permeability, and voltage-dependent magnesium block.

Previous studies have revealed the structure of the NMDA receptor in an inhibited mode induced by binding of the antagonist compound ifenprodil. Now, investigators at Cold Spring Harbor Laboratory (NY, USA) have used X-ray crystallography, single-particle electron cryomicroscopy (cryoEM), and electrophysiology to establish the structure of rat NMDA receptors in active and non-active mode.

They reported in the May 2, 2016, online edition of the journal Nature that the bi-lobed structure of GluN2 ATD adopted an open conformation accompanied by rearrangement of the GluN1–GluN2 ATD heterodimeric interface. These changes led to additional rotations at various points throughout both the ATD and LBD, causing the ion channel pore to open.

"The NMDA receptor architecture itself is quite complicated," said senior author Dr. Hiro Furukawa, an associate professor at Cold Spring Harbor Laboratory, "but most recently we have been really fascinated by how each of its domains moves in a sophisticated but organized manner. With the technology available today, we do not see continuous movement but instead we see snapshots of NMDA receptors in different functional states."

"Unless we have a library of molecular structures, people in the field will not be able to run those simulations," said Dr. Furukawa. "We hope that this new finding will help pharmacologists come up with better therapeutic compounds that have minimal side effects."

Related Links:
Cold Spring Harbor Laboratory

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Strips
11 Parameter Urine Strips
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.